Kwality Pharmaceuticals receives approval from INVIMA for Ampoule and Vial product lines
Voydeya approved in the EU as add-on treatment to ravulizumab
AbbVie's phase 3 Select -GCA study of Upadacitinib showed positive results in patients with giant cell arteritis
Bristol Myers Squibb and Cellares inks US$ 380 million capacity reservation for the manufacture of CAR T Cell Therapies
Vertex announces advancements of Suzetrigine in acute and neuropathic pain
Roche gets FDA approval for Alecensa in early lung cancer
Mac-Chem Products (India)’s Boisar facility renews EU-GMP certification
Akums launches Bharosa campaign
Marksans Pharma updates on USFDA inspection at Verna, Goa manufacturing facility
Zydus launches Mirabegron ER Tablets in the US
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes